Skip to main content
Open Access Publications from the University of California


UCLA Previously Published Works bannerUCLA

Insulin-Degrading Enzyme Inhibition, a Novel Therapy for Type 2 Diabetes?

Published Web Location
No data is associated with this publication.

The insulin-degrading enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer's disease susceptibility gene, though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item